Reveal DDR pathway dependencies with an expertly curated DNA damage response cell panel screen.

Looking to unlock mechanistic insights and gain a deeper understanding of DNA damage response (DDR) pathway dependencies?

Our upcoming DDR cell panel screen from our Preclinical Services team delivers a comprehensive, functionally annotated dataset to help accelerate your drug discovery program – delivering actionable insights up to 40% faster and with up to 20% cost savings.

Register your interest today and our team will be in touch to discuss your needs.

Leveraging our OncoSignature™ platform, this DDR cell panel screen will provide you with:

•	Convenience of a pre-curated panel
•	Curated genomic and phenotypic annotations to guide interpretation
•	Standard of care (SOC) benchmark data
•	2D, 3D and biologics assay data
•	Fast results in around 8-10 weeks
•	Attractive pricing with up to 20% off

Available for a limited time only!

Please register your interest and submit a final scope of work by June 30^th, 2026 to qualify.

Check out our other upcoming focused cell panel screens here.

Exclusions may apply. Please contact your local sales representative for details.

For research only. Not for use in diagnostic procedures.

Business or institution email*

First Name*

Last Name*

Company or institution*

Business Phone (optional)

Country

Postal code*

By providing my personal data and clicking the submit button, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy (provided below).